title: Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
authors.forename: D
authors.initials: D
authors.lastname: Milojkovic
authors.forename: A
authors.initials: A
authors.lastname: Mijovic
authors.forename: C G
authors.initials: CG
authors.lastname: Taylor
authors.forename: G J
authors.initials: GJ
authors.lastname: Mufti
authors.forename: A
authors.initials: A
authors.lastname: Pagliuca
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000601:surgery; D012008:Recurrence; D000069283:Rituximab; D016879:Salvage Therapy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor; D000069283:Rituximab